microRNA-34a modulates the senescence of activated hepatic stellate cells in alcohol-associated liver injury

被引:0
|
作者
Slevin, Elise
Wan, Ying
Harrison, Kelly
Zhang, Yudian
Li, Xuedong
Li, Tian
Lorenzo, Sugeily R.
Xu, Wenjuan
Klaunig, James E.
Shetty, Ashok K.
Meng, Fanyin
机构
[1] Indiana Center for Liver Research, Richard L. Roudebush VA Medical Center and Division of Gastroenterology and Hepatology, Indiana University School of Medicine, IN, Indianapolis
[2] Baylor Scott & White Memorial Hospital, TX, Temple
[3] University Park, PA
[4] Indiana School of Public Health, Indiana University, IN, Bloomington
[5] Institute for Regenerative Medicine, Texas A&M College of Medicine, TX
来源
FASEB JOURNAL | 2022年 / 36卷
关键词
D O I
10.1096/fasebj.2022.36.S1.R4231
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BACKGROUND: Reversion of activated hepatic stellate cells (HSCs) to quiescence is likely to be a promising pathway in liver fibrosis regression. The development of senescence in HSCs during alcoholic liver injury may lead to liver compensation against fibrosis. The current study aims to characterize the functional role of miR-34a regulated cellular senescence during alcohol-associated hepatitis. METHODS: Senescence related gene and miR-34a expression was assessed using a PCR Array and/or real-time PCR analysis. Cellular senescence in cultured HSCs were measured by SA-β-gal staining. Senescence mediators were defined in LPS treated hepatic stellate cells in vitro, and in TLR-4 knockout mice or morpholino antisense oligomer against miR-34a (miR-34a Morpho/AS) treated mice with chronic ethanol feeding in vivo. RESULTS: We identified that 5 weeks of ethanol feeding significantly increased the total liver histopathology score and miR-34a expression, along with the activation of hepatic stellate cells marked by enhanced α-SMA staining. Treatment of HSCs with LPS (20 ng/ml) for 24 hr significantly increased miR-34a expression, along with the enhanced SA-β-gal activity, up-regulated α-SMA/Collagen A1 expression and increased cellular viability. Silencing of miR-34a decreased LPS-induced activation in HSCs by downregulation of fibrosis markers α-SMA, Col1a1 and TIMP-1, and increased SA-β-gal activity as well as the cellular senescence marker CCl2, whereas silencing of the LPS receptor, TLR4, decreased this marker in the same group of HSCs, suggesting anti-miR-34a reversed LPS-mediated HSC activation through inducing cellular senescence. Furthermore, the expression of miR-34a and verified miR-34a related senescence marker CCl2 were significantly altered in hepatic stellate cells from ethanol-fed mouse liver specimens compared to controls. TLR4 knockout mice and miR-34a Morpho/AS treated mice displayed less sensitivity to alcoholic injury, along with enhanced SA-β-gal activity and CCl2 level in HSCs, and recovered expressions of α-SMA, Col1a1 and TIMP-1. SUMMARY AND CONCLUSION: Our results show that miR-34a mediated cellular senescence is essential for the potential reversion from activated to quiescent hepatic stellate cells during alcohol-associated hepatitis. These findings provide new insight into the function of microRNA regulated cellular senescence in human HSCs and increase opportunities for the development of novel treatment paradigms for the management of alcohol-associated liver diseases. © FASEB.
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Cytotoxic NK cells phenotype and activated lymphocytes are the main characteristics of patients with alcohol-associated liver disease
    Coral Zurera-Egea
    Aina Teniente-Serra
    Daniel Fuster
    Eva Martínez-Cáceres
    Roberto Muga
    Paola Zuluaga
    Clinical and Experimental Medicine, 2023, 23 : 3539 - 3547
  • [42] Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
    Dan Li
    Li He
    Huizhuang Guo
    Hanwei Chen
    Hong Shan
    EJNMMI Research, 5
  • [43] CYP1B1+PRRX1+NR4A2+ HEPATIC STELLATE CELLS IN ALCOHOL-ASSOCIATED HEPATITIS
    Choi, Hye Yeon
    Daniel, Yoann
    Sinha, Sonal
    Pan, Stephanie
    Bai, Yixin
    Yang, Qihong
    Kim, Hyun Young
    Sakane, Sadatsugu
    Weber, Ryan
    Sun, Zhaoli
    Ng, Stanley
    Li, Meng
    Kisseleva, Tatiana
    HEPATOLOGY, 2024, 80 : S728 - S728
  • [44] Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
    Li, Dan
    He, Li
    Guo, Huizhuang
    Chen, Hanwei
    Shan, Hong
    EJNMMI RESEARCH, 2015, 5 : 1 - 10
  • [45] Liver fibrosis: New insights into migration of activated hepatic stellate cells
    Yang, CQ
    Zeisberg, M
    Mosterman, B
    Sudhakar, A
    Yerramalla, U
    Afdhal, N
    Kalluri, R
    GASTROENTEROLOGY, 2002, 122 (04) : A653 - A653
  • [46] Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
    Mello, Aline
    Hsu, Ming-Fo
    Koike, Shinichiro
    Chu, Bryan
    Cheng, Jeff
    Yang, Jun
    Morisseau, Christophe
    Torok, Natalie J.
    Hammock, Bruce D.
    Haj, Fawaz G.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 11 (03): : 815 - 830
  • [47] Peritumoral activated hepatic stellate cells are associated with hepatic recurrence for resectable colorectal adenocarcinoma liver metastasis following resection
    Deng, Li
    Li, Taiyuan
    Liao, Yuanyuan
    Liu, Shuang
    Xie, Zhen
    Huang, Zhixiang
    Dai, Hua
    Li, Jianfeng
    Lei, Xiong
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [48] LOSS OF HEPATIC TRANSCRIPTION FACTOR EB ATTENUATES ALCOHOL-ASSOCIATED LIVER CARCINOGENESIS
    Ding, Wen-Xing
    Chao, Xiaojuan
    Ni, Hong-Min
    HEPATOLOGY, 2021, 74 : 230A - 230A
  • [49] Extracellular signal-regulated kinase modulates hepatic stellate cell proliferation and chemotaxis and is activated by in vivo liver injury.
    Marra, F
    Arrighi, C
    Fazi, M
    Caligiuri, A
    Pinzani, M
    Romanelli, RG
    Laffi, G
    Gentilini, P
    HEPATOLOGY, 1998, 28 (04) : 539A - 539A
  • [50] Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis
    Chao, Xiaojuan
    Wang, Shaogui
    Hlobik, Madeline
    Ballabio, Andrea
    Ni, Hong-Min
    Ding, Wen-Xing
    AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (01): : 87 - 103